Cell Therapy Market Size to Reach USD 38.24 Billion by 2034, Exhibiting a Strong CAGR of 21.05%

Cell Therapy Market Outlook:

The therapeutic use of cells to address medical issues or illnesses is known as cell therapy. Cells or tissues are transplanted into a patient's body to repair or replace damaged cells or tissues. Cell therapy can potentially cure a wide range of ailments, including cancer, cardiovascular disease, neurological disorders, and autoimmune diseases. It consists of many different types of cells, including stem cells, immunological cells, and cells from other organs.

According to Straits Research, the global cell therapy market size was estimated at USD 6.88 billion in 2025 and is anticipated to grow from USD 8.29 billion in 2026 to USD 38.24 billion in 2034, growing at a CAGR of 21.05% from 2026 to 2034.

Download the Sample Pages of this Report for Better Understanding @ https://straitsresearch.com/report/cell-therapy-market/request-sample

Key Highlights

Based on cell type, the global market is bifurcated into stem cell therapies and non-stem cell therapies. The stem cell therapies segment dominates the global market and is expected to exhibit a CAGR of 6.5% over the forecast period.

Based on therapeutic areas, the global cell therapy industry is segmented into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and other research uses. The malignancies segment dominates the global market and is predicted to exhibit a CAGR of 16.3% during the forecast period.

Based on therapy type, the global market is divided into allogenic therapies and autologous therapies. The autologous therapies segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 17.8% over the forecast period.

North America is the most significant global cell therapy market shareholder and is estimated to exhibit a CAGR of 14.8% over the forecast period.

Cell Therapy Market Segmentation

By Product
Media, Sera, and Reagents
Cell Engineering products
Cell Culture Vessels
Cell Therapy Equipment
Cell Processing Equipment
Single-use equipment
Other Equipment
System and Software
Other Products

By Cell Type
T-Cells
Stem Cells
Other Cells

By Cell Process
Cell Processing
Cell Preservation, Distribution, and Handling
Process Monitoring and Quality Control

By End User
Biopharmaceutical and Biotechnology companies
CRO's and CMOs
Research Institutes & Cell Banks

Get Detailed Market Segmentation @ https://straitsresearch.com/report/cell-therapy-market/segmentation

Market Dynamics

The Rising Number of Clinical Studies for Cellular Therapies Drives the Global Market

Cellular treatments have a lot of therapeutic potential in various clinical settings. As a result, there has been a significant global investment in research and clinical translation. Rapid advances in stem cell research offer the potential to address unmet disease management requirements in the pharmaceutical, biotech, and medical industries. Clinical studies are being conducted on several undiscovered therapies. Moreover, the growth in the number of ongoing clinical trials can be ascribed to the continuing availability of grants from government and corporate funding sources to support initiatives at various phases of clinical trials. As a result, the aforementioned aspect will drive the global market.

Approval of Kymriah and Yescarta across Various Countries Creates Tremendous Opportunities

The encouraging outcomes of Kymriah and Yescarta in treating leukemia and lymphoma have resulted in rapid regulatory clearance for these medications in several nations. They have received FDA, EMA, Health Canada, and Japanese regulatory approval. Similarly, Kymriah will be approved by Chinese regulatory authorities in the next years. These approvals have resulted in a significant surge in studies for CAR T-cell treatments in a variety of malignancies.

In the coming years, therapeutic techniques based on adoptive cell transfer are anticipated to advance substantially. Kymriah was manufactured for 11 countries and 35 accredited treatment centers at the end of the first quarter of 2018. Such factors create opportunities for market growth over the forecast period.

To Visit Here For Grab More Insights @ https://straitsresearch.com/report/cell-therapy-market

Competitive Players

Gilead Sciences
Novartis
Vericel Corporation
Smith Nephew Kite Pharma, Inc.
Osiris Therapeutics
Celgene Corporation
Medipost Co., Ltd.
Adaptimmune Therapeutics plc.
NuVasive, Inc.

Regional Analysis

North America is the most significant global cell therapy market shareholder and is estimated to exhibit a CAGR of 14.8% over the forecast period. The growing prevalence of chronic diseases, greater investment in research and development, and favorable government policies supporting cell therapy use are all driving factors in the North American cell therapy industry. Moreover, the large number of clinical trials conducted in North America promotes the region's market growth.

Furthermore, the rising desire for personalized treatment and public knowledge of the benefits of cell therapy is expected to provide new business opportunities in the field. The North American market is very competitive, with established and new competitors. The leading competitors in the industry are growing through joint ventures, acquisitions, and partnerships to obtain a competitive edge. Overall, the North American cell therapy market is expected to grow considerably in the coming years, owing to increased demand for innovative medications and a stronger emphasis on personalized medicine.

Recent Developments

May 2023: The FDA awarded Novartis' Kymriah CAR T-cell therapy expedited approval for treating pediatric acute lymphoblastic leukemia.

February 2023: Yescarta, a CAR T-cell therapy approved by the FDA for treating relapsed or refractory diffuse large B-cell lymphoma, was developed by Kite Pharma, a subsidiary of Gilead Sciences.

Inquiry Before Buying @ https://straitsresearch.com/buy-now/cell-therapy-market

List of Related Reports:

Cell and Gene Therapy Market Size: https://straitsresearch.com/report/cell-and-gene-therapy-market

Gene Therapy Cell Culture Media Market Size: https://straitsresearch.com/report/gene-therapy-cell-culture-media-market

Cell Therapy Processing Market Size: https://straitsresearch.com/report/cell-therapy-processing-market

Autologous Cell Therapy Market Size: https://straitsresearch.com/report/autologous-cell-therapy-market

Cell and Gene Therapy Manufacturing Market Size: https://straitsresearch.com/report/cell-and-gene-therapy-manufacturing-market

Cell and Gene Therapy Manufacturing QC Market Size: https://straitsresearch.com/report/cell-and-gene-therapy-manufacturing-qc-market

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/

About Us:

StraitsResearch.com is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

This release was published on openPR.